This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rubin, S. A. Articles by Swan, H. J. Search for Related Content PubMed PubMed Citation Articles by Rubin, S. A. Articles by Swan, H. J.

Circulation, Vol 66, 143-148, Copyright © 1982 by American Heart Association

ARTICLES

Arterial oxygenation and arterial oxygen transport in chronic myocardial failure at rest, during exercise and after hydralazine treatment

SA Rubin, HV Brown and HJ Swan

Arterial oxygen transport (cardiac output x arterial oxygen content) may be decreased in heart failure. We studied the determinants of arterial oxygen transport in 15 patients with chronic, severe myocardial failure at rest and during cycle ergometry. During control therapy at rest, arterial oxygen tension was normal (81 +/- 8 mm Hg, mean +/- SD) and increased slightly during exercise (90 +/- 14 mm Hg). During hydralazine therapy at rest, arterial oxygen tension was slightly higher (87 +/- 9 mm Hg) and also increased during exercise (92 +/- 15 mm Hg). Hydralazine did not increase arterial oxygen tension (0.10 greater than p greater than 0.05), but exercise did (p less than 0.02). Arterial oxygen saturation and content were normal and did not change under any condition or treatment. During control therapy at rest, arterial oxygen transport was low (313 +/- 74 ml/min . m2) and remained abnormally low during exercise (434 +/- 124 ml/min . m2). During hydralazine therapy, arterial oxygen transport was higher at rest (457 +/- 100 ml/min . m2) and during exercise (577 +/- 131 ml/min . m2). Hydralazine increased arterial oxygen transport (p less than 0.01) because it increased stroke volume at rest and during exercise, but it did not change arterial oxygenation. Arterial oxygenation is normal in chronic heart failure patients at rest and during exercise. Hydralazine increases cardiac output and arterial oxygen transport without changing arterial oxygenation.

This article has been cited by other articles:

				L. Ingle Prognostic value and diagnostic potential of cardiopulmonary exercise testing in patients with chronic heart failure Eur J Heart Fail, February 1, 2008; 10(2): 112 - 118. [Abstract] [Full Text] [PDF]

				C. Liu, G. M. Balanos, M. Fatemian, T. G. Smith, K. L. Dorrington, and P. A. Robbins Effects of hydralazine on the pulmonary vasculature and respiratory control in humans Exp Physiol, January 1, 2008; 93(1): 104 - 114. [Abstract] [Full Text] [PDF]

				P. Agostoni, M. Bussotti, G. Cattadori, E. Margutti, M. Contini, M. Muratori, G. Marenzi, and C. Fiorentini Gas diffusion and alveolar-capillary unit in chronic heart failure Eur. Heart J., November 1, 2006; 27(21): 2538 - 2543. [Abstract] [Full Text] [PDF]

				M. Guazzi Alveolar-Capillary Membrane Dysfunction in Heart Failure: Evidence of a Pathophysiologic Role Chest, September 1, 2003; 124(3): 1090 - 1102. [Abstract] [Full Text] [PDF]

				K. K.A. Witte and A. L. Clark Is the elevated slope relating ventilation to carbon dioxide production in chronic heart failure a consequence of slow metabolic gas kinetics? Eur J Heart Fail, August 1, 2002; 4(4): 469 - 472. [Abstract] [Full Text] [PDF]

				P Faggiano, A D'Aloia, A Gualeni, and A Giordano Relative contribution of resting haemodynamic profile and lung function to exercise tolerance in male patients with chronic heart failure Heart, February 1, 2001; 85(2): 179 - 184. [Abstract] [Full Text]

				D. E. O'DONNELL, C. D'ARSIGNY, S. RAJ, H. ABDOLLAH, and K. A. WEBB Ventilatory Assistance Improves Exercise Endurance in Stable Congestive Heart Failure Am. J. Respir. Crit. Care Med., December 1, 1999; 160(6): 1804 - 1811. [Abstract] [Full Text]

				S. Puri, D. P. Dutka, B. L. Baker, J. M. B. Hughes, and J. G. F. Cleland Acute Saline Infusion Reduces Alveolar-Capillary Membrane Conductance and Increases Airflow Obstruction in Patients With Left Ventricular Dysfunction Circulation, March 9, 1999; 99(9): 1190 - 1196. [Abstract] [Full Text] [PDF]

				M. Guazzi, G. Marenzi, M. Alimento, M. Contini, and P. Agostoni Improvement of Alveolar–Capillary Membrane Diffusing Capacity With Enalapril in Chronic Heart Failure and Counteracting Effect of Aspirin Circulation, April 1, 1997; 95(7): 1930 - 1936. [Abstract] [Full Text]

				S. Puri, B. L. Baker, D. P. Dutka, C. M. Oakley, J. M. B. Hughes, and J. G. F. Cleland Reduced Alveolar–Capillary Membrane Diffusing Capacity in Chronic Heart Failure : Its Pathophysiological Relevance and Relationship to Exercise Performance Circulation, June 1, 1995; 91(11): 2769 - 2774. [Abstract] [Full Text]

				J. Myers and V. F. Froelicher Hemodynamic Determinants of Exercise Capacity in Chronic Heart Failure Ann Intern Med, September 1, 1991; 115(5): 377 - 386. [Abstract] [PDF]

				A. H. Glassman, L. L. Johnson, E.-G. V. Giardina, B. T. Walsh, S. P. Roose, T. B. Cooper, and J. T. Bigger Jr The Use of Imipramine in Depressed Patients With Congestive Heart Failure JAMA, October 21, 1983; 250(15): 1997 - 2001. [Abstract] [PDF]